Could a malaria drug help kids with rare lung disease?
NCT ID NCT03822780
First seen Mar 21, 2026 · Last updated May 18, 2026 · Updated 10 times
Summary
This study looked at whether hydroxychloroquine, a medicine used for malaria and autoimmune conditions, can help children with a rare genetic lung disease that affects surfactant—a substance that keeps lungs open. 25 children with confirmed genetic mutations took the drug, and doctors checked if their oxygen needs improved over 6 months. The goal was to see if the drug could control the disease, not cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SURFACTANT DYSFUNCTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Children's hospital of Fudan University
Shanghai, Shanghai Municipality, 201102, China
Conditions
Explore the condition pages connected to this study.